Mylan Inc., which provides products to customers in approximately 150 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust pipeline; operates the world's third largest active pharmaceutical ingredient manufacturer; and runs a specialty business focused on respiratory and allergy therapies.

Recent Releases

May 17, 2013
Mylan Launches Generic Tricor® Tablets

May 15, 2013
Mylan Launches Generic Zomig® Tablets

View all releases »

Events & Presentations

May 22, 2013 at 9:30 AM ET
UBS 2013 Global Healthcare Conference

View all events & presentations »